Avia Pharma acquires two dermatology products from Perrigo

On December 31, 2019, Avia Pharma acquired the rights to ACO Karbamid and ACO Glycerol from Perrigo.

-We are particularly pleased to be the owner of two high quality Perrigo products. The acquisition is fully in line with our goal of owning products both within self-care products as well as within prescription drugs, says Jacob Calmvik, CEO of Avia Pharma.

ACO Karbamid and ACO Glycerol will be renamed Curemid and Cremarol in the fall of 2020. The products are now registered only in Sweden, but are expected to be registered in additional countries.